B. Braun To Invest Another 1.6bn Euros
B. Braun Melsungen AG has adopted a new worldwide investment program worth 1.6bn euros for the period 2011 to 2014 to build new production sites and to extend existing ones. The projects in the current investment program will probably all be finished by 2011. According to current plans, the new program will begin in the same year. It is planned, among other projects, to build a third Life factory and a new works council and company medical services building at the Pfieffewiesen premises in Melsungen. Further, since the laboratory is moving to a new central laboratory, the rooms at Stadtwaldpark in which a large part of the laboratory has been housed so far need to be converted for new use.
The investment program is, however, not restricted to Melsungen. The location in Malaysia is to be renewed, a new factory for infusion solutions is to be built in Indonesia and the sites in Brazil and Argentina are to be expanded.
The term of the second investment program cannot yet be named definitively because the program is to be financed from the company’s operating cash flow. “We want to finance the planned projects ourselves,” says Prof. Dr. h. c. Ludwig Georg Braun. “How quickly we are able to implement them depends on how successful the company is in the next few years.”
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
